Overview

Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy

Status:
Recruiting
Trial end date:
2022-07-10
Target enrollment:
Participant gender:
Summary
Sixty patients scheduled for elective laparoscopic cholecystectomy will be randomly assigned using sealed envelope into two equal groups (30 patients each). Group 1: will receive bilateral ESP block with injection of 20 ml of 0.25% Bupivacaine in each site of injection . Group 2: will receive bilateral ESP block with injection of 18ml of 0.25% Bupivacaine plus 2ml dexmedetomidine 0.5 ug /kg in each site of injection .
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tanta University
Treatments:
Bupivacaine
Dexmedetomidine